[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Page 21858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08214]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP) GH20-001, Develop, Implement, and Evaluate
Evidence-Based, Innovative Approaches To Prevent, Find, and Cure
Tuberculosis in High-Burden Settings; GH20-002, Malaria Operations
Research To Improve Malaria Control and Reduce Morbidity and Mortality
in Western Kenya; GH20-003, Conducting Public Health Research in
Colombia; GH20-004, Conducting Public Health Research in Georgia; and
GH20-005, Conducting Public Health Research in South America; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--GH20-001, Develop, Implement, and Evaluate Evidence-based,
Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-
Burden Settings; GH20-002, Malaria Operations Research to Improve
Malaria Control and Reduce Morbidity and Mortality in Western Kenya;
GH20-003, Conducting Public Health Research in Colombia; GH20-004,
Conducting Public Health Research in Georgia; and GH20-005, Conducting
Public Health Research in South America; April 14-16, 2020, 9:00 a.m.-
2:00 p.m., EDT, in the amended FRN.
The teleconference, which was published in the Federal Register on
April 1, 2020, Vol. 85, No. 63, page 18243, is being amended to change
the meeting dates and times to: April 14-15, 2020, from 9:00 a.m.-2:00
p.m., EDT. The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Ph.D., Scientific Review
Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Atlanta,
Georgia 30329-4027, Telephone (404) 639-4796; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-08214 Filed 4-17-20; 8:45 am]
BILLING CODE 4163-18-P